Characterizing overall survival in AML patients: A competing risk analysis of SEER data covering 46 years

Background: The analysis of trends in overall survival after leukemia is an ongoing research field [ref:1], [ref:2], [ref:3], [ref:4]. We characterized the improvement in overall survival after acute myeloid leukemia (AML) over 46 years based on US registry data. [for full text, please go to the a.m. URL]

Institutions

Publication Details

Journal
German Medical Science (German Research Foundation)
Published
2025-11-03
DOI
https://doi.org/10.3205/25gmds150
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characterizing overall survival in AML patients: A competing risk analysis of SEER data covering 46 years

German Medical Science (German Research Foundation)
Acute Myeloid Leukemia Research
article

Characterizing overall survival in AML patients: A competing risk analysis of SEER data covering 46 years

article en

Abstract

Background: The analysis of trends in overall survival after leukemia is an ongoing research field [ref:1], [ref:2], [ref:3], [ref:4]. We characterized the improvement in overall survival after acute myeloid leukemia (AML) over 46 years based on US registry data. [for full text, please go to the a.m. URL]

German Medical Science (German Research Foundation)
University of Bremen (DE), University of Münster (DE)
Openalex Percentile: Top 31%
Acute Myeloid Leukemia Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Characterizing overall survival in AML patients: A competing risk analysis of SEER data covering 46 years · German Medical Science (German Research Foundation) (2025) | TGRS Research Map | TGRS